Skip to main content
Equibles
COSM logo

COSM · Cosmos Health Inc. · Metrics

Track COSM — free

Use COSM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research COSM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.30 +0.01 (+4.93%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 18, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the date of this filing.”
View the 10-Q filed Aug 18, 2026
Market Cap
$29.17M
Shares
100.63M
Volume · Nov 6 1.05M Avg daily vol (3M) 3.01M

COSM metrics

82 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.30
Market cap
$29.17M

Price action

23 metrics
Price change (1W)
+4.5%
Price change (30D)
-9.7%
Price change (3M)
+31.2%
Price change (6M)
-17.2%
Price change (YTD)
-41.8%
Price change (1Y)
-60.0%
Trailing year
Price change (5Y)
-92.4%
52-week high
$0.73
52-week low
$0.17
Change from 52-week high
-60.3%
Change from 52-week low
+68.5%
Annualized volatility
98.0%
Annualized volatility (3M)
111.2%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.5
RSI (14D)
47.4
Price vs SMA 50
-5.7%
Price vs SMA 200
-5.6%
Avg volume (3M)
3.04M
Relative volume
0.4
Average dollar volume
$914,244

Company

3 metrics
Sector
Healthcare
Industry
Medical Distribution
Shares outstanding
100.63M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 241.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 252.7%
P / book
1.4
reciprocal yield 70.9%
FCF yield
-34.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-83.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.4×
reciprocal yield 276.2%
EV / revenue historical average (5Y)
0.5×
reciprocal yield 221.1%
EV / EBIT historical average (3Y)
84.9×
reciprocal yield 1.2%
EV / EBIT historical average (5Y)
84.9×
reciprocal yield 1.2%
EV / EBITDA historical average (3Y)
41.1×
reciprocal yield 2.4%
EV / EBITDA historical average (5Y)
41.1×
reciprocal yield 2.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
10.3%
Operating margin
-24.9%
Trailing 12 months
Net margin
-33.1%
Gross profit (TTM)
$7.57M
Operating profit (TTM)
−$18.33M
Net income (TTM)
−$24.39M
Trailing 12 months
Diluted EPS (TTM)
$-0.66
FCF margin
-13.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.45

Growth

11 metrics
Revenue growth YoY
+28.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$73.73M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+108.4%
Year over year · more shares
Revenue CAGR (3Y)
+9.0%
Revenue CAGR (5Y)
+3.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-118.0%
Return on assets
-39.7%
Debt / equity
0.2
Current ratio
1.1
EBITDA (TTM)
−$16.95M
Free cash flow (TTM)
−$9.93M
Quick ratio
0.9
Interest coverage
-7.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.36M
Latest balance sheet
Cash & equivalents
$1.80M
Total assets
$61.46M
Total debt
$3.19M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$9.84M
Capital expenditures (TTM)
$95,647
R&D (TTM)
$497,649
SG&A (TTM)
—
Stock compensation (TTM)
$2.25M
R&D / revenue
0.7%
Stock compensation / revenue
3.0%

Ownership (13F)

9 metrics
13F filers
23
13F filer change QoQ
+1
Institutional ownership
2.3%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
0.6%
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
+62.5%
Holder tenure
6.8
Price vs estimated holder cost
-86.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.5%

Short interest

3 metrics
Short interest
2.3%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
42 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1474167 CUSIP 221413305 13F (30d) 13 filings 9 filers Visit website Investor relations